Amanote Research
Register
Sign In
Hepatitis B Reactivation in Chronic Hepatitis C Patients Treated With Interferon or Pan-Oral Direct-Acting Antivirals
Hepatology
- United States
doi 10.1002/hep.29620
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Hepatology
Date
December 19, 2017
Authors
Jiaye Liu
Publisher
Wiley
Related search
Editorial: Hepatitis B Reactivation in Patients With Chronic Hepatitis C Treated With Direct-Acting Antivirals - Incidence, Severity of Hepatitis and Lessons to Learn
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Evaluation of Hepatitis B Reactivation Among 62,920 Veterans Treated With Oral Hepatitis C Antivirals
Hepatology
Medicine
Hepatology
Letter: Hepatitis B Virus Reactivation in Patients With Chronic Hepatitis C During Direct-Acting Anti-Viral Therapy
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Treating Hepatitis B Virus/Hepatitis C Virus Coinfected Patients With Direct-Acting Hepatitis C Virus Antivirals Only Is Not Safe
Hepatology
Medicine
Hepatology
Reactivation of Herpesvirus in Patients With Hepatitis C Treated With Direct-Acting Antiviral Agents
Clinical Gastroenterology and Hepatology
Hepatology
Gastroenterology
Treatment Efficacy of All-Oral Combinations of Direct-Acting Antivirals in Chronic Hepatitis C Patients With NS5A-P32 Deletion
Acta Hepatologica Japonica
Hepatology
Editorial: Direct-Acting Antivirals Decrease the Frequency of Diabetes Complications in Patients With Chronic Hepatitis C
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Increased Incidence or Recurrence of Hepatocellular Carcinoma in Hepatitis C Virus Cirrhotic Patients Treated With Direct-Acting Antivirals: Myth or Fact?
Expert Review of Anticancer Therapy
Oncology
Pharmacology
Letter: Low Rates of HBV Serology Testing in Patients With Chronic Hepatitis C Receiving Direct Acting Antivirals
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
